Vicapsys Life Sciences, Inc. financial data

Location
1735 Buford Highway, Ste. 215 113, Cumming, GA
State of incorporation
FL
Fiscal year end
December 31
Former names
SSGI, INC. (to 11/7/2016)
Latest financial report
10-Q - Q3 2024 - Jan 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 11.2 % +58.8%
Return On Equity 58.1 % -39.2%
Return On Assets -686 % -129%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32.4M shares
Common Stock, Shares, Outstanding 32.4M shares +0.94%
Entity Public Float 4.66M USD
Common Stock, Value, Issued 32.4K USD +0.94%
Weighted Average Number of Shares Outstanding, Basic 34.3M shares -0.23%
Weighted Average Number of Shares Outstanding, Diluted 34.3M shares -0.23%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 14.1K USD +14.7%
General and Administrative Expense 92.3K USD +41.9%
Operating Income (Loss) -1.11M USD -9.32%
Nonoperating Income (Expense) -36.6K USD +43.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.35M USD -24.8%
Net Income (Loss) Attributable to Parent -1.35M USD -24.8%
Earnings Per Share, Basic -0.04 USD/shares -33.3%
Earnings Per Share, Diluted -0.04 USD/shares -33.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 89.6K USD +67.3%
Assets, Current 89.6K USD -57%
Assets 89.6K USD -57%
Accounts Payable, Current 537K USD +97.4%
Liabilities, Current 2.74M USD +77.3%
Retained Earnings (Accumulated Deficit) -17.1M USD -8.6%
Stockholders' Equity Attributable to Parent -2.65M USD -98.3%
Liabilities and Equity 89.6K USD -57%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.42K USD +5.37%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 32.4M shares +0.94%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.42K USD +5.37%
Interest Paid, Excluding Capitalized Interest, Operating Activities 212 USD
Deferred Tax Assets, Valuation Allowance 2.99M USD +8.9%
Deferred Tax Assets, Operating Loss Carryforwards 2.99M USD +8.9%
Preferred Stock, Shares Authorized 7.44M shares -62.8%
Additional Paid in Capital 14.4M USD +0.27%
Interest Expense 9.95K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%